Moxifloxacine Vioser (Moxifloxacin)

• Moxifloxacin is indicated for several bacterial infections affecting different organ systems.
• Community‑acquired pneumonia: effective treatment of adult patients with CAP caused by susceptible organisms.
• Acute bacterial sinusitis: resolves infection and alleviates sinus inflammation.
• Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves respiratory function.
• Skin and skin structure infections: eradicates susceptible skin pathogens.
• Complicated intra‑abdominal infections: provides broad‑spectrum coverage for mixed aerobic and anaerobic bacteria.

• Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to these targets, the drug prevents bacterial DNA synthesis and transcription, leading to rapid bacterial cell death. Its activity covers a wide range of Gram‑positive, Gram‑negative and atypical organisms.

Moxifloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects

• Nausea: transient stomach upset reported in many patients.
• Diarrhea: loose stools that usually resolve after treatment.
• Headache: mild to moderate pain often improves with rest.
• Dizziness: occasional sensation of light‑headedness.
• Rash: skin redness or mild itching.
• Elevated liver enzymes: temporary increase in hepatic markers.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or rupture, especially in the Achilles.
• QT interval prolongation: may lead to cardiac arrhythmias.
• Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.
• Clostridioides difficile infection: severe colitis after disruption of gut flora.
• Hepatic failure: rare but potentially life‑threatening liver injury.
• Peripheral neuropathy: numbness or tingling in extremities.

Before using Moxifloxacine Vioser, consider the following safety measures.

• Renal impairment: monitor kidney function and adjust therapy as needed.
• Hepatic impairment: use with caution; observe liver function tests.
• History of tendon disorders: avoid use in patients with prior tendon injury.
• Concomitant QT‑prolonging drugs: obtain baseline ECG and monitor cardiac rhythm.
• Pregnancy and lactation: prescribe only when benefits outweigh potential risks.
• Store at below 25°C: keep in the original container, protect from moisture and light.

Moxifloxacine Vioser can interact with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid)

• Concurrent use with other fluoroquinolones: increased risk of toxicity.
• Co‑administration with systemic corticosteroids: heightened chance of tendon rupture.
• Combination with drugs that prolong QT interval (e.g., macrolides, antiarrhythmics): risk of serious cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• Nonsteroidal anti‑inflammatory drugs (NSAIDs): may reduce antibacterial efficacy.
• Antacids containing aluminum or magnesium: can impair absorption if given simultaneously.
• Warfarin: monitor INR closely for potential anticoagulant effect alteration.